Anti-Aging Potential: Key Mechanisms & Research

GLP-1 drugs show promise in slowing biological aging by influencing pathways related to inflammation, oxidative stress, and cellular senescence, with initial human trials indicating a reduction in biological aging markers.

The top 3

1. Main Anti-Aging Pathways Influenced: GLP-1 RAs protect against oxidative stress, cellular senescence, and chronic inflammation, which are major risk factors and underlying mechanisms of aging.
2. Leading Research in GLP-1 Anti-Aging: Researchers at the University of California San Diego and Duke University are actively investigating how GLP-1 medications affect aging, with studies exploring their impact on biological aging markers and mechanisms.
3. Current Status of Human Trials: A randomized, placebo-controlled human trial showed that semaglutide slowed the pace of cellular aging by 9% and lowered biological age scores in adults with HIV, though more research in broader populations is needed.

Sources

• GLP-1 receptor agonists and SGLT2 inhibitors: new anti-aging tools? - PMC
• Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases
• GLP-1 Receptor Agonists and the Hallmarks of Aging: A Systems-Level Analysis
• GLP-1 drugs like Ozempic, Wegovy may help slow biological aging - Medical News Today
• Scientists Say This Ultra-Popular Medication May Slow Biological Aging - Prevention
• GLP-1 Anti-Aging and Longevity Benefits: A Way to Fight Inflammation? - Healthline

Open the full topic